Practice Areas
• Ms. Grace Pengpeng Yan is managing partner of the Hong Kong office. She is admitted to practice in China, New York State and Hong Kong SAR. She has extensive experience in corporate and securities law matters for public companies, emerging growth companies, private equity and venture capital firms. • Ms. Yan has structured and effected M&A, corporate finance transactions for publicly and privately held companies. • Ms. Yan represents corporate issuers and investment banks in debt and equity offerings in the public and private markets both in China and overseas, including the Chinese stock exchange, NASDAQ, Hong Kong stock exchange and Singapore stock exchange.
• Ms. Yan represents financial and strategic investors and target companies in various Fund investment, M&A, recapitalization and restructuring transactions in and outside China, including HSBC, Intel Capital Corporation, Cinven, Qualcomm Corporation, UN Industry Development Organization and GE Medical System Co., Ltd.
Representative Experience
• Secondary listing by PC Partner Group Limited (stock code: PCT ) on the main Board of the Singapore Exchange Securities Trading Limited
• Initial public offering and listing by CMGE Technology Group Limited on the Hong Kong Stock Exchange Main Board (stock code: 0302)
• Initial public offering and listing by Financial Street Property Co. Limited on the Hong Kong Stock Exchange Main Board ( stock code: 1502)
•Zhejiang Tsingsong Investment Management Co.,Ltd round A investment as lead investor in a Cayman company specializing in medical instrument and equipment R&D.
•Listing by Million Hope Industries Holdings Limited on the Hong Kong Stock Exchange Main Board (stock code: 1897)
• Initial public offering and listing by Kidsland International Holdings Limited on the Hong Kong Stock exchange Main Board (stock code 2122)
• de-listing and going-private of China Mobile Games and Entertainment Group Limited from NASDAQ
• Listing by China Mobile Games and Entertainment Group Limited on NASDAQ;
• NASDAQ listed company CASI Pharmaceuticals, Inc. (CASI） At-the-Market Offering.
• NASDAQ listed company Cellular Biomedicine Group Inc. (CBMG) public offering of its common stock
• Listing by New Ray Medicine International Holding Limited on Hong Kong Stock Exchange GEM (stock code: 8180); • Initial public offering by PC Partner Group Limited and listed on Hong Kong Stock Exchange (stock code: 1263); • Listing by China Assurance Finance Group Limited on Hong Kong Stock Exchange GEM (stock code: 8090); • Listing by Life Tech Scientific Corporation on Hong Kong Stock Exchange GEM (stock code: 8122);
• Listing by Fairson Holdings Limited on Hong Kong Stock Exchange GEM (stock code: 8132);
• Initial public offering by Hui Xian Real Estate Investment Trust and listed on Hong Kong Stock Exchange (stock code: 87001)
• Initial public offering by ShiFang Holding Limited on Hong Kong Stock Exchange (stock code: 1831); • Datang Telecom Technology & Industry Holdings Co., LTD invested US$172 million in common equity in SMIC (Semiconductor Manufacturing International Corporation NYSE: SMI, HKSE: 981) for a 16.6% interest
• The acquisition by Sinopec (HKSE : 0386, SHSE : 600028) of eight oil product pipeline from Sinopec Sales & Industrial Company;
• Initial public offering by China Boqi Environmental Solutions Technology (Holdings) Co. Ltd and traded on TSE in Japan (Stock Code : 1412);
• Secondary offering by A-Power Energy Generation Systems, Ltd. (NASDAQ listed company, stock code: APWR);
• Initial public offering by China Medical and traded on NASDAQ (Stock Code :CMED);
• Initial public offering by China Techfaith Wireless Communication Technology Ltd. and traded on NASDAQ (Stock Code : CNTF);
• The reverse merger by Beijing Origin Co. with Origin Agritech (NASDAQ national market company, Stock Code : SEED);
• Huiheng Medical, Inc. traded on OTCBB by way of SPAC (Stock Code： HHGM);
• China Techfaith Wireless Communication Technology Limited invested by HSBC, Intel Capital Corporation, Qualcomm Corporation and Seabright China Special Opportunities Limited;
• Zhuhai Power Plant 3&4 invested by Cheung Kong Infrastructure Holdings Limited (HKSE : 1038);
• The acquisition by the China Academy of Launch Vehicle Technology of CASIL Telecommunications Holdings Ltd. (HKSE : 1185);
Honors
•Ranked as “Leading Lawyer in Capital Markets/M&A “ by IFLR1000 for 13 years from 2025 to 2013
• Ranked as “Leading Lawyer in Corporate/M&A “by Chambers Global Guide 2013 and 2014
• Highly recommended in “Private Equity”;“M&A”; “Project & Energy” and “WTO international trade” by The Legal 500 Asia Pacific from 2022 to 2018 continuously
• Awarded as “ALB Dealmakers of Asia (HK)” in 2021 and 2020
• Nominated as “Dealmaker of the Year” and “Managing Partner of the Year” by 2020 19th ALB Hong Kong Law Awards
• Nominated as “China Dealmaker of the Year “by ALB China Law Awards 2013
Admissions
• China
• New York
• Hong Kong
Professional Experience
• Partner, Guantao Law Firm (Since 2003);
• International Associate, Simpson Thacher & Bartlett LLP (2007~2008);
Education Background
• Chicago-Kent College of Law, Illinois Institute of Technology ,LL.M
• China University of Political Science and Law , Master of Law
• China University of Political Science and Law, Bachelor of Law
Languages
Chinese; English
Email: yan@guantao.com
